A Study to Evaluate U3-1402 in Subjects With Advanced or Metastatic Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2346224
下载链接
链接失效反馈官方服务：
资源简介：
This study is designed to primarily evaluate the safety and efficacy of U3-1402 in participants with advanced or metastatic colorectal cancer (CRC) who have received at least 2 prior lines of therapy and will explore clinical benefit according to human epidermal growth factor receptor 3 (HER3) tumor expression level in otherwise refractory tumors.
创建时间：
2020-09-15
